BioNTech and CureVac after takeover
BioNTech and CureVac after takeover BioNTech among top players in mRNA and vaccines after CureVac acquisition The planned acquisition of CureVac announced yesterday makes strategic sense for BioNTech. BioNTech justifies the acquisition with its improved positioning in mRNA technologies. [...]